Technology Networks

01/03/2026

PFAS pollution is increasingly detected in the environment and some have been implicated in cancer and hormone imbalances.

Researchers found that certain forever chemicals were strong predictors of epigenetic aging in men, but not in women.

Two non-legacy PFAS, namely perfluorononanoic acid (PFNA) and perfluorooctanesulfonamide (PFOSA), appear to speed up biological aging in middle-aged men, but not women. Learn more here.

28/02/2026

Most rare diseases have a genetic origin and are biologically complex, and since each rare disease affects such a small portion of the population, they are not commercially attractive to the pharmaceutical industry.

Patient-led organizations have stepped in to fund the costly, early-stage academic development of treatments for rare diseases, like Ataxia-Telangiectasia A-T Society and Cystic Fibrosis Trust.

Read more: https://bit.ly/474asij

28/02/2026

There are over 7,000 known rare diseases, many with few treatment options.

Drug development for rare diseases faces smaller patient populations and higher costs associated.

We with Rebecca Jansen, associate vice president at Bora Pharmaceuticals, about the challenges in rare disease drug development, emerging technologies that could transform the field, and they can meet patient needs.

Read more: https://bit.ly/4kYixeg

27/02/2026

Bipolar disorder and schizophrenia share many symptoms and even genetic overlap, creating a long-standing psychiatric riddle.

Recently, researchers identified separate genetic pathways for each, highlighting how two people with the same diagnosis can have very different outcomes.

Read more: https://bit.ly/4rGF1CT

26/02/2026

The science is in—cannabis-induced munchies are real.

A new study found that cannabis triggers a rapid increase in food intake by hijacking reward signals in the brain and overriding normal signals of being full.

Read more: https://bit.ly/4bbcmA1

26/02/2026

(Ad): Looking for a tailored approach to chromatography?

Waters Corporation have the solution, from their user-friendly systems to their training and services.

Visit their Supplier Hub to find out more: https://technet.works/chromatography-supplier-hu

25/02/2026

Most gene therapy approaches focus on fixing or replacing a single faulty gene. However, this has created a system where thousands of rare diseases each need their own separate therapy.

Transfer RNA therapeutics act later in the process, when cells make proteins, which means that one therapy could potentially work across many diseases that share the same type of genetic error.

The chief scientific officer of Alltrna spoke to Technology Networks about how this approach could change the way genetic diseases are treated.

Read more: https://bit.ly/46tTV73

25/02/2026

📣 Save the date!

At the webinar, Dr. Zivjena Vucetic will teach you how single-cell technologies are transforming our understanding of leukemia progression and cell-to-cell communication.

📆 March 26, 11am EDT

Register for FREE via the link in the comments.

24/02/2026

Pregnancy alters a woman's brain, and subsequent pregnancies remodel the brain in different ways than the first.

While social networks of the brain are changed during the first pregnancy, researchers found that a mother’s attention and physical coordination are sharpened during her second pregnancy.

Read more: https://bit.ly/4aFtcFK

24/02/2026

Next-generation sequencing is reshaping healthcare and public health.

In this Ask the Expert session, Dr. Deborah Cragun will answer your pressing questions on genomic technologies.

📆 March 31, 11am EST

Register for FREE via the link in the comments and get your q's in!

23/02/2026

Biomarkers are transforming oncology, neurology, immunology, and beyond.

The eBook explores the latest advances shaping biomarker discovery.

Get your FREE copy via the link in the comments.

23/02/2026

In our new editorial series, we are shining a spotlight on reproductive health.

For the first installment, we explore how exposure to environmental pollutants can impact fertility.

Read the article via the link in the comments.